Infliximab: A novel treatment option for refractory orofacial granulomatosis [3]

Acta Dermato-Venereologica

Volumn 87, Issue 3, 2007, Pages 265-266

  Peitsch, Wiebke K ^a   Kemmler, Nicole ^a   Goerdt, Sergij ^a   Goebeler, Matthias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ADULT; CASE REPORT; CLINICAL EXAMINATION; GENERAL PRACTITIONER; HUMAN; LABORATORY TEST; LETTER; MALE; OROFACIAL GRANULOMATOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; GRANULOMATOSIS, OROFACIAL; HUMANS; MALE;

EID: 34447502534     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0219     Document Type: Letter

References (11)

1. Wiesenfeld D, Ferguson MM, Mitchell DN, MacDonald DG, Scully C, Cochran K, et al. Oro-facial granulomatosis - a clinical and pathological analysis. Q J Med 1985; 54: 101-113.
2. Ziem PE, Pfrommer C, Goerdt S, Orfanos CE, Blume-Peytavi U. Melkersson-Rosenthal syndrome in childhood: a challenge in differential diagnosis and treatment. Br J Dermatol 2000; 143: 860-863.
3. van der Waal RI, Schulten EA, van der Meij EH, van de Scheur MR, Starink TM, van der Waal I. Cheilitis granulomatosa: overview of 13 patients with long-term follow-up - results of management. Int J Dermatol 2002; 41: 225-229.
4. Sciubba JJ, Said-Al-Naief N. Orofacial granulomatosis: presentation, pathology and management of 13 cases. J Oral Pathol Med 2003; 32: 576-585.
5. Chang JT, Lichtenstein GR. Drug insight: antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 220-228.
6. Mahadevan U, Sandborn WJ. Infliximab for the treatment of orofacial Crohn's disease. Inflamm Bowel Dis 2001; 7: 38-42.
7. Barry O, Barry J, Langan S, Murphy M, Fitzgibbon J, Lyons JF. Treatment of granulomatous cheilitis with infliximab. Arch Dermatol 2005; 141: 1080-1082.
8. Thomas P, Walchner M, Ghoreschi K, Röcken M. Successful treatment of granulomatous cheilitis with thalidomide. Arch Dermatol 2003; 139: 136-138.
9. Kano Y, Shiohara T, Yagita A, Nagashima M. Association between cheilitis granulomatosa and Crohn's disease. J Am Acad Dermatol 1993; 28: 801.
10. Ehlers S. Why does tumor necrosis factor targeted therapy reactivate tuberculosis? J Rheumatol Suppl 2005; 74: 35-39.
11. British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 2005; 60: 800-805.